За последние два года количество биомедицинских компаний – участников Фонда «Сколково» выросло почти на 200%, а их выручка приблизилась к 200 млн долларов. Такие данные привела вице-президент Фонда, исполнительный директор биомед-кластера...
ФИЛАДЕЛЬФИЯ. Понедельник на BIO начинается во вторник. Крупнейшее ежегодное событие для биомедицинской индустрии, которое в нынешнем году проходит в Филадельфии, по традиции стартовало с партнеринга, и только на следующий день открылась выставка участников...
Более десяти биомедицинских компаний - участников «Сколково» получили возможность представить свои проекты топ-менеджерам Johnson & Johnson, сообщил Sk.ru директор по развитию и работе с ключевыми партнерами кластера биомедицинских технологий...
Three innovative biomed projects were selected as the winners of the Patents Power competition last week organised by the Skolkovo Foundation, the German pharma company Bayer and Rospatent, Russia’s federal intellectual property service. Finalists...
The fifth Pharma’s Cool educational programme for students and young entrepreneurs began on Monday at the Skolkovo Technopark. Organised by the Skolkovo Foundation’s biomed cluster and Open University Skolkovo (OPUS), Pharma’s Cool aims...
Компания «Сингента», один из мировых лидеров в области производства средств защиты растений и семеноводства, открыла в Сколково лабораторию по исследованию и контролю качества растительного материала. Предполагаемый объем инвестиций «Сингенты»...
The Skolkovo Foundation has teamed up with the multinational pharmaceutical and life sciences company Bayer to launch a competition to help biotech startups advance their projects and secure their intellectual property rights. The competition, titled Patents...
After a gruelling boot camp and months of preparations, six Russian biomed startups were selected Thursday to take part in the first AstraZeneca-Skolkovo accelerator, in which the companies will get intensive support from the multinational pharma giant for...
A large part of the Skolkovo innovations ecosystem is preparing to head north to Russia’s second city this week for the annual St. Petersburg International Economic Forum ( SPIEF ), which takes place on May 24-26. Skolkovo startups and foundation...
В "Сколково" завершилось строительство уникального диагностического центра. Это первая клиника, созданная на базе нового международного медицинского кластера. Здесь можно будет пройти обследование с помощью новейшего оборудования и на ранней стадии...
The Skolkovo Foundation signed a landmark agreement with the global pharmaceutical company AstraZeneca on Tuesday on the setting up of a corporate accelerator programme for biomed startups working on treatments and diagnosis systems for cancer, cardiovascular...
A pair of very special speakers took part in a conference devoted to 3D bioprinting in space at the Skolkovo innovation centre on Wednesday. Two cosmonauts – commander Anton Shkaplerov and flight engineer Oleg Artemyev – answered questions and interacted...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
A new lab opened at the Skolkovo Technopark on Wednesday that looks set to drastically improve the diagnosis of cancer patients across Russia. Russia’s first digital lab was opened by UNIM , a resident of Skolkovo’s biomed cluster that uses...
The Skolkovo Foundation has joined forces with the U.K.’s AMR Centre, a private-public initiative launched in 2016 to support and accelerate the development of new antibiotics, to combat the global problem of antimicrobial resistance. Skolkovo's...
The Skolkovo Foundation has signed a cooperation agreement with Janssen, a Belgium-headquartered subdivision of U.S. pharma giant Johnson & Johnson, with the aim of boosting innovative pharmaceutical research, including through financial support. Priority...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
The first shared lab space in Russia for life sciences and biotech startups opened its doors at the Skolkovo Technopark on Wednesday with a mission to help budding biomed entrepreneurs test their theories and turn their ideas into a commercial company. ...
The Golden Autumn agricultural trade fair is to a large extent a celebration of Russian traditions. Individual regions of Russia present their local produce on their own stand, often accompanied by people dressed in folk costumes who sing, dance or play traditional...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
Fourteen Skolkovo biomed startups are currently taking part in the BIO International Convention 2017 in San Diego, California. The four-day convention, which began on June 19, is devoted to the research and development of innovative healthcare, agricultural...
Ведущий кубинский биомедицинский концерн BioCubaFarma назначил регионального представителя в России. Выпускница биофака МГУ Идания Кабальеро Торрес будет представлять в Москве интересы 31 компании и 64 производственных объединений, входящих в Группу BioCubaFarma...
The Skolkovo Foundation has signed a strategic partnership agreement with the multinational pharmaceuticals giant AstraZeneca to carry out joint scientific research and educational activities in Russia. Irina Panarina, director of AstraZeneca Russia and...
Half of all Russian-origin innovative pharmaceuticals are developed by Skolkovo Foundation startups, Kirill Kaem, head of the organisation’s biomed cluster, told a meeting of the foundation’s council on Monday evening. Of about 1,400 pharmaceuticals...